Esperion Therapeutics, Inc.
ESPR
DELAYED 1 MONTH
8 insider filings · Latest: May 28, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 16 8:20 PM | Benjamin LookerChief Legal Officer | Grant/Award | 269,230 | $2.44 | 269,230(D) | View → |
| Mar 13, 2026 | Mar 16 8:20 PM | Sheldon L. KoenigDirector, President and CEO | Grant/Award | 647,460 | $2.44 | 647,460(D) | View → |
| Mar 13, 2026 | Mar 16 8:19 PM | Benjamin HalladayChief Financial Officer | Grant/Award | 221,270 | $2.44 | 221,270(D) | View → |